HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lei, T. Articles by Adams, E. F. Search for Related Content PubMed PubMed Citation Articles by Lei, T. Articles by Adams, E. F.

Growth hormone releasing peptide (GHRP-6) is a synthetic hexapeptide which specifically stimulates secretion of growth hormone (GH) by pituitary somatotrophs. The precise intracellular mechanism by which this is achieved has not been deciphered although it is known to involve protein kinase C (PKC) and Ca²⁺ but to be cAMP-independent. We have used cell cultures of human pituitary somatotrophinomas to demonstrate powerful effects of GHRP-6 on membrane phosphatidylinositol (PI) turnover, a second messenger system which leads to activation of PKC and mobilisation of intracellular Ca²⁺ reserves. Incubation of somatotrophinoma cells with GHRP-6 led to a dose-dependent stimulation of rate of PI turnover. GH secretion was increased in parallel. Effects were discernable after only 15 minutes incubation and rose to a maximum at 2 hours. PI turnover was stimulated by GHRP-6 in 8 of 8 tumours examined, effects ranging from 2.1–7.9 fold increases. Stimulation of GH secretion by GHRP-6 was independent of presence of gsp oncogenes, emphasising the cAMP-independent nature of its effects. These results provide evidence that the GH-stimulatory effects of GHRP-6 are achieved through activation of the PI second messenger system and thus support earlier findings that PKC and Ca²⁺ play central roles in mediating the effects of GHRP-6.

(PI) into diacylglycerol (DAG) and inositol phosphates (Nishizuka, 1988; Berridge and Irvine, 1989), raising the possibility that GHRP-6 acts by stimulating this intracellular second messenger system. To test this hypothesis, we have examined whether GHRP-6 is able to promote increased PI turnover in human pituitary somatotrophinoma cells in culture.

This article has been cited by other articles:

				R. D. Kineman, J. Kamegai, and L. A. Frohman Growth Hormone (GH)-Releasing Hormone (GHRH) and the GH Secretagogue (GHS), L692,585, Differentially Modulate Rat Pituitary GHS Receptor and GHRH Receptor Messenger Ribonucleic Acid Levels Endocrinology, August 1, 1999; 140(8): 3581 - 3586. [Abstract] [Full Text]

				N. Shah, W. S. Evans, C. Y. Bowers, and J. D. Veldhuis Tripartite Neuroendocrine Activation of the Human Growth Hormone (GH) Axis in Women by Continuous 24-Hour GH-Releasing Peptide Infusion: Pulsatile, Entropic, and Nyctohemeral Mechanisms J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2140 - 2150. [Abstract] [Full Text]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				M. M. Skinner, R. Nass, B. Lopes, E. R. Laws, and M. O. Thorner Growth Hormone Secretagogue Receptor Expression in Human Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4314 - 4320. [Abstract] [Full Text]

				K. Hanew, A. Utsumi, A. Tanaka, H. Ikeda, and Y. Yokogoshi Secretory Mechanisms of Growth Hormone (GH)-Releasing Peptide-, GH-Releasing Hormone-, and Thyrotropin-Releasing Hormone-Induced GH Release in Patients with Acromegaly J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3578 - 3583. [Abstract] [Full Text]

				E. Adams and M. Buchfelder Comment on Human Fetal Pituitary Expresses Functional GHRP Receptorsd J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2216 - 2216. [Full Text]

				E. F. Adams, B. Huang, M. Buchfelder, A. Howard, R. G. Smith, S. D. Feighner, L. H. T. van der Ploeg, C. Y. Bowers, and R. Fahlbusch Presence of Growth Hormone Secretagogue Receptor Messenger Ribonucleic Acid in Human Pituitary Tumors and Rat GH3 Cells J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 638 - 642. [Abstract] [Full Text]

				S. D. Feighner, A. D. Howard, K. Prendergast, O. C. Palyha, D. L. Hreniuk, R. Nargund, D. Underwood, J. R. Tata, D. C. Dean, C. P. Tan, et al. Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues Mol. Endocrinol., January 1, 1998; 12(1): 137 - 145. [Abstract] [Full Text]

				P. A. Bennett, G. B. Thomas, A. D. Howard, S. D. Feighner, L. H. T. Van der Ploeg, R. G. Smith, and I. C. A. F. Robinson Hypothalamic Growth Hormone Secretagogue-Receptor (GHS-R) Expression Is Regulated by Growth Hormone in the Rat Endocrinology, November 1, 1997; 138(11): 4552 - 4557. [Abstract] [Full Text] [PDF]